Scientific article
English

Update in Drug Development for Chronic HBV/HDV Infection

Published in

Current hepatology reports, vol. 18, no. 4, p. 522-530

Publication date

2019-12

First online date

2019-11-27

Abstract

Purpose of Review: Chronic hepatitis D is the most severe form of viral hepatitis. Currently, no drug has been approved for its treatment and pegylated interferon alpha remains the only recommended therapy, with dismal efficiency and important side effects. This review summarizes the recent advances in drug development for chronic hepatitis D.

Recent Findings: A better knowledge of virology of hepatitis D virus has led to the development of several drugs targeting different steps of the viral life cycle. Among them, bulevirtide (a viral entry inhibitor, formerly denominated as Myrcludex B), lonafarnib (a viral assembly inhibitor), REP-2139-Ca (an inhibitor of HBsAg secretion), and pegylated interferon lambda have shown promising results in phase II clinical trials.

Summary: In the near future, new therapeutic options will be available for the treatment of chronic hepatitis D. However, no drug is currently under development targeting viral replication and an effective treatment strategy may require combination of several drugs.

Keywords

  • Chronic hepatitis D
  • Hepatitis D virus
  • Therapeutics
  • Clinical trials

Citation (ISO format)

ALFAIATE, Dulce, NEGRO, Francesco. Update in Drug Development for Chronic HBV/HDV Infection. In: Current hepatology reports, 2019, vol. 18, n° 4, p. 522–530. doi: 10.1007/s11901-019-00503-y

Main files (1)

Article (Published version)

Identifiers

Additional URL for this publication

http://link.springer.com/10.1007/s11901-019-00503-y

Journal ISSN

2195-9595
10views
0downloads

Technical informations

Creation

29/05/2026 12:25:07

First validation

30/06/2026 08:01:17

Update

30/06/2026 08:36:04

Status update

30/06/2026 08:36:04

Last indexation

30/06/2026 08:36:05
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated